{"retracted":false,"update":{"timestamp":1447113600000,"doi":"10.1371/journal.pone.0142802","type":"correction"},"doi":"10.1371/journal.pone.0138348","journal":"PLOS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis"}
